Real-World Treatment Patterns and Clinical Outcomes in Canadian Patients with AML Unfit for First-Line Intensive Chemotherapy

Real-World Treatment Patterns and Clinical Outcomes in Canadian Patients with AML Unfit for First-Line Intensive Chemotherapy

Acute myeloid leukemia (AML) is a hematological malignancy that predominantly affects the elderly. Prognosis declines with age. For those who cannot tolerate intensive chemotherapy, historically established treatment options have been hypomethylating agents (HMAs), low dose cytarabine (LDAC), and be...

Full description

Bibliographic Details
Main Authors: David Sanford, Pierre Desjardins, Brian Leber, Kristjan Paulson, Sarit Assouline, Paola M. C. Lembo, Pierre-André Fournier, Heather A. Leitch
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Current Oncology
Subjects:
acute myeloid leukemia
real-world evidence
treatment patterns
chemotherapy-ineligible
outcomes
Online Access:https://www.mdpi.com/1718-7729/29/10/535

Similar Items

Similar Items